- 询价
- Nebulabio
- 中国
- NBL-291752
- 2026年01月06日
企业认证
相关产品推荐更多 >
![Anilazine, KLH [Antigen]](https://img1.dxycdn.com/p/s14/2025/0919/905/8275649941890498691.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant BCCV Gn/Glycoprotein N Protein, 19-482aa, His-tag
中文名称：重组Black Creek Canal orthohantavirus Gn/Glycoprotein N蛋白
别名：Envelopment polyprotein, Glycoprotein precursor, M polyprotein, Glycoprotein N, Gn, Glycoprotein G1, GP
货号：NBL-291752
品牌：Nebulabio
规格：100UG；1MG；Bulk
| 产品描述
NebuSelect™ Recombinant BCCV Gn/Glycoprotein N Protein, His-tag (Cat# NBL-291752) is expressed in E. coli. This recombinant protein is of high purity, verified to be greater than 90% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay.
| 产品属性
Species:Black Creek Canal orthohantavirus
Expression System:E. coli
Molecular Weight:53 kDa
Target Name:Gn/Glycoprotein N
Purity:>90% by SDS-PAGE.
Formulation:See COA
Endotoxin:＜1 EU/ug(LAL Method)
Storage:4°C for short term. -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The Use of TAGZyme for the Efficient Removal of N-Terminal His-Tags
The use of affinity tags and especially histidine tags (His-tags) has become widespread in molecular biology for the efficient purification of recombinant proteins. In some cases, the presence of the affinity tag in the recombinant protein
Small scale His-Tag fusion protein purification under denaturative conditions
Small scale His-Tag fusion protein purification under denaturative conditions Introduction High levels of expression of recombinant proteins in a bacterial system can lead to the formation of insoluble aggregates
Quality Assessment of Recombinant Proteins Produced in Plants
Plant-based expression technologies for recombinant proteins have begun to receive acceptance for pharmaceuticals and other commercial markets. Protein products derived from plants offer safer, more cost-effective, and less capital-intensive
技术资料暂无技术资料 索取技术资料
